Hemofiltration: Treating and preventing infection

Clinical Microbiology and Infection

Volumn 2, Issue 2, 1996, Pages 80-85

  Turner, Paul C ^a   Humphreys, Hilary ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Catheterization; Hemofiltration; Infection; Intensive care; Kidney failure

Indexed keywords

EID: 0013692765     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1996.tb00210.x     Document Type: Review

References (62)

1. Henderson LW. Haemofiltration. Kidney 1987; 20: 25-30.
2. Kramer P, Wigger W, Rieger J, Mathaei D, Scheler F. Arteriovenous hemofiltration: a new and simple method for the treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 1977; 55: 1121-22.
3. Firth JD. Renal replacement therapy on the intensive care unit. QJ Med 1993; 86: 75-7.
4. Tominaga GT, Ingegno M, Ceraldi C, Waxman K. Vascular complications of continuous arteriovenous haemofiltration in trauma patients. J Trauma 1993; 35: 285-9.
5. Morgenstern DZ. What's in a name? Pediatr Nephrol 1990; 4: 643-4.
6. Voerman HJ, Strack van Schijndel RJM, Thijs LG. Continuous arterial-venous haemodiafiltration in critically ill patients. Crit Care Med 1990; 18: 911-14.
7. Macias WL, Mueller DA, Scarim SK, Robinson M, Rudy DW. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991; 18: 451-8.
8. Kierdorf H. Continuous versus intermittent treatment: clinical results in acute renal failure. Contrib Nephrol 1991; 93: 1-12.
9. Pinson JM. Preventing complications in the CAVH patient. Dimen Crit Care Nursing 1992; 11: 242-8.
10. McClelland P. The use of haemofiltration in critical care. The method of choice for support? B J Intensive Care 1993; 3: 449-53.
11. Nahman NS, Middendorf DF. Continuous arteriovenous hemofiltration. Med Clin North Am 1990; 74: 975-84.
12. Elliott TSJ, Faroqui MH, Armstrong RF, Hanson GC. Guidelines for good practice in central venous catheterization. J Hosp Infect 1994; 28: 163-76.
13. Recker D. Catheter-related sepsis: an analysis of the research. Dimen Crit Care Nursing 1992; 11: 249-62.
14. Elliott TSJ. Line-associated bacteraemias. Commun Dis Rep CDR Rev 1993; 3: R91-6.
15. Johnson A, Oppenheim BA. Vascular catheter-related sepsis; diagnosis and prevention. J Hosp Infect 1992; 20: 67-78.
16. Weightman NC, Simpson EM, Speller DCE, Mott MG, Oakhill A. Bacteraemia related to indwelling central venous catheters: prevention, diagnosis and treatment. Eur J Clin Microbiol Infect Dis 1988; 7: 125-9.
17. Yagupsky P, Nolte FS. Quantitative aspects of septicaemia. Clin Microbiol Rev 1990; 3: 269-79.
18. Raad II, Brodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197-210.
19. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-6.
20. Storck M, Hard WH, Inthorn D. Septic shock and multiple organ failure: treatment with haemofiltration? Intensive Care Med 1991; 17: 372-3.
21. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus induced septicaemia in immature swine. Crit Care Med 1993; 21: 914-24.
22. Grootendorst AF, van Bommel EFH, van de Hoven B, van Leengoed LAMG, van Osta ALM. High volume haemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992; 18: 235-40.
23. Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16: 494-9.
24. Gomez A, Wang R, Unruh H et al. Hemofiltration reverses left ventricular dysfunction in dogs. Anaesthesiology 1990; 73: 671-85.
25. Freeman BD, Yatsiv I, Natanson C, et al. Continuous ateriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 1995; 180: 286-92.
26. Goldfarb S, Golper TA. Proinflammatory cytokines and hemofiltration membrane. J Am Soc Nephrol 1994; 5: 228-32.
27. Bellomo R, Tipping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 1995; 17: 457-66.
28. Schetz M, Ferdinande P, van den Berghe G, Verwaest C, Lauwers P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995; 21: 169-76.
29. Groeneveld ABJ. Septic shock and, multiple organ failure: treatment with haemofiltration? Intensive Care Med 1990; 16: 489-90.
30. Barton IK, Hilton PJ, Taub NA, et al. Acute renal failure treated by haemofiltration: factors affecting outcome. Q J Med 1993; 86: 81-90.
31. Best C, Walsh J, Sinclair J, Beattie J. Early haemodiafiltration in meningococcal septicaemia. Lancet 1996; 347: 202.
32. Gant V, Maciver C, Treacher DF. Veno-venous haemodiafiltration in meningococcal septicaemia. Lancet 1996; 347: 612.
33. Warnholtz A, Slater AD, Golper TA. Continuous arteriovenous hemofiltration in the critically ill patient. J Ky Med Assoc 1991; 89: 111-14.
34. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N. A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically ill. Renal Failure 1993; 15: 595-602.
35. Livornesr LL, Benz RL, Ingerman MJ, Santoro J. Antibacterial agents in renal failure. Infect Dis Clin North Am 1995; 9: 591-614.
36. Bressolle F, Kinowski JM, Delacoussaye JE, Wynn N, Eledjam JJ, Galtier M. Clinical pharmacokinetics during continuous hemofiltration. Clin Pharmacokinet 1994; 26: 457-71.
37. Vos MC, Vincent HH, Yzerman EPF, Vogel M, Mouton JW. Drug clearance by continuous haemodiafiltration. Results with the AN-69 capillary haemofilter and recommended dose adjustments for seven antibiotics. Drug Invest 1994; 7: 315-22.
38. Cotterill S. Antimicrobial prescribing in patients on haemofiltration. J Antimicrob Chemother 1995; 36: 773-80.
39. Sandford JP, Gilbert DN, GerberdingJL, Sande MA. Guide to antimicrobial therapy. Dallas: Antimicrobial Therapy Inc. 1995: 110-13.
40. Weiss LG, Cars O, Danielson BG, Grahnen A, Wikstrom B. Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration. Clin Nephrol 1988; 30: 282-6.
41. Davies SP, Lacey LF, Kox WJ, Brown EA. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis. Nephrol Dial Transplant 1991; 6: 971-6.
42. Hasegawa H, Takahashi K, Imada A, Horiuchi A. Pharmacokinetics of cefotaxime and desacetylcefotaxime in renal failure patients undergoing continuous arteriovenous haemofiltration. Drugs 1988; 35 (suppl 2): 78-81.
43. Andrassy K. Pharmacokinetics of cefotaxime in dialysis patients. Diag Microbiol Infect Dis 1995; 22: 85-7.
44. Keller E, Fetcht H, Bohler J, Schollmeyer P. Single dose kinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration in intensive care patients. Nephrol Dial Transplant 1989; 4: 640-5.
45. Vos MC, Vincent HH, Yzerman EPF. Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous haemodiafiltration (CAVHD). Intensive Care Med 1992; 18: 282-5.
46. Robert R, Rochard E, Malin F, Bouquet S. Amikacin pharmacokinetics during continuous veno-venous hemofiltration. Crit Care Med 1991; 19: 588-99.
47. Ernest D, Cutler DJ. Gentamicin clearance during continuous arteriovenous hemodiafiltration. Crit Care Med 1992; 20: 586-9.
48. Slugg PH, Haug MT, Bosworth C, Paganini EP. Comparative vancomycin kinetics in intensive care unit patients with acute renal failure: intermittent hemodialysis versus continuous hemofiltration hemodialysis. Contrib Nephrol 1991; 93: 140-2.
49. Reetze-Bonorden P, Böhler J, Kohler C, Schollmeyer P, Keller E. Elimination of vancomycin in patients on continuous arteriovenous hemodialysis. Contrib Nephrol 1991; 93: 135-9.
50. Bellomo R, Ernest D, Parkin G, Boyce N. Clearance of vancomycin during continuous arteriovenous hemodiafiltration. Crit Care Med 1990; 18: 181-3.
51. Rawer P, Seim KE. Elimination of vancomycin during hemofiltration. EurJ Clin Microbiol 1989; 8: 529-31.
52. Davies SP, Azadian BS, Kox WJ, Brown EA. Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis. Nephrol Dial Transplant 1992; 7: 848-54.
53. Fish DN, Bainbridge JL, Poloquin LA. Variable disposition of ciprofloxacin in critically ill patients undergoing continuous arteriovenous haemodiafiltration. Pharmacotherapy 1995; 15; 236-45.
54. Paap CM, Nahata MC. Clinical use of trimethoprim/ sulfamethoxazole during renal dysfunction. DICP, Ann Pharmacother 1989; 23: 646-54.
55. UK Renal Pharmacy Group. An A-Z of drug use and guide to patient counselling in renally impaired adults. Spring 1994.
56. Humphreys H, Oliver D, Winter R, Warnock D. Liposomal amphotericin B and continuous venous-venous haemofiltration. J Antimicrob Chemother 1994; 33: 1071-2.
57. Scholz J, Schulz M, Steinfath M, Hover S, Bause H. Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient. J Mol Med 1995; 73: 145-7.
58. Lau AH, Kronfol NO. Elimination of flucytosine by continuous hemofiltration. Am J Nephrol 1995; 15: 327-31.
59. Jones T, Alderman C. Acyclovir clearance by CAVHD. Intensive Care Med 1991; 17: 125-6.
60. Boulieu R, Bastien O, Bleyzac N. Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous haemodialysis. Ther Drug Monit 1993; 15: 105-7.
61. Bastien O, Boulieu R, Bleyzac N, Estanove S. Clinical use of ganciclovir during renal failure and continuous haemodialysis. Intensive Care Med 1994; 20: 47-8.
62. Foscarnet. In: APBI Data sheet compendium 1995-96. London: Datapharm Publications Ltd. 1995: 130-1.